Statistics for The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease
Total visits
views | |
---|---|
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease | 422 |
Total visits per month
views | |
---|---|
January 2024 | 1 |
February 2024 | 3 |
March 2024 | 1 |
April 2024 | 7 |
May 2024 | 4 |
June 2024 | 0 |
July 2024 | 0 |
File Visits
views | |
---|---|
Roberts_2019_Kawasaki.pdf | 864 |
Top country views
views | |
---|---|
United States | 215 |
Germany | 112 |
China | 27 |
Sweden | 7 |
Ukraine | 7 |
United Kingdom | 4 |
Turkey | 3 |
Canada | 2 |
France | 2 |
Japan | 2 |
South Korea | 2 |
Russia | 2 |
Singapore | 2 |
Austria | 1 |
Switzerland | 1 |
India | 1 |
Kazakhstan | 1 |
Malaysia | 1 |
Saudi Arabia | 1 |
Top city views
views | |
---|---|
Kiez | 53 |
Wilmington | 53 |
Gunzenhausen | 51 |
Fairfield | 24 |
Kansas City | 18 |
Houston | 14 |
Shenzhen | 11 |
Ling | 10 |
White Plains | 9 |
Cambridge | 8 |
Nürnberg | 8 |
Kiev | 7 |
Jacksonville | 6 |
Stockholm | 6 |
Washington | 6 |
Ann Arbor | 5 |
San Francisco | 5 |
Beijing | 2 |
Charlotte | 2 |
Jackson | 2 |
Ordu | 2 |
Paris | 2 |
Saint Louis | 2 |
Sejong | 2 |
Singapore | 2 |
Toronto | 2 |
Almaty | 1 |
Bengaluru | 1 |
Birmingham | 1 |
Chicago | 1 |
Clearwater | 1 |
Commack | 1 |
Detroit | 1 |
Falls Church | 1 |
Gilbert | 1 |
Helena | 1 |
Istanbul | 1 |
Kista | 1 |
Lake Mary | 1 |
London | 1 |
Matsuyama | 1 |
Moscow | 1 |
New York | 1 |
Osaka | 1 |
Riva | 1 |
Riyadh | 1 |
Saint Petersburg | 1 |
Seattle | 1 |
Seremban | 1 |
Tustin | 1 |
Vienna | 1 |
Zürich | 1 |